| pubmed-article:1902076 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1902076 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
| pubmed-article:1902076 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
| pubmed-article:1902076 | lifeskim:mentions | umls-concept:C0002475 | lld:lifeskim |
| pubmed-article:1902076 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:1902076 | lifeskim:mentions | umls-concept:C0019134 | lld:lifeskim |
| pubmed-article:1902076 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:1902076 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:1902076 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
| pubmed-article:1902076 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1902076 | pubmed:dateCreated | 1991-5-23 | lld:pubmed |
| pubmed-article:1902076 | pubmed:abstractText | Adjuvant perioperative liver infusion chemotherapy with fluorouracil, mitomycin and heparin caused mild but significant myelosuppression in the first two postoperative weeks. This was associated with a slightly increased bleeding tendency. Mortality was not increased. Future trials might combine chemotherapy with hematopoietic growth factors in order to minimize myelosuppression. | lld:pubmed |
| pubmed-article:1902076 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1902076 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1902076 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1902076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1902076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1902076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1902076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1902076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1902076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1902076 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1902076 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:1902076 | pubmed:author | pubmed-author:WeberWW | lld:pubmed |
| pubmed-article:1902076 | pubmed:author | pubmed-author:MetzgerUU | lld:pubmed |
| pubmed-article:1902076 | pubmed:author | pubmed-author:LafferUU | lld:pubmed |
| pubmed-article:1902076 | pubmed:author | pubmed-author:EgeliRR | lld:pubmed |
| pubmed-article:1902076 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1902076 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:1902076 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1902076 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1902076 | pubmed:pagination | 365-8 | lld:pubmed |
| pubmed-article:1902076 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:meshHeading | pubmed-meshheading:1902076-... | lld:pubmed |
| pubmed-article:1902076 | pubmed:articleTitle | Hematological toxicity of adjuvant portal liver infusion with fluorouracil, mitomycin and heparin. | lld:pubmed |
| pubmed-article:1902076 | pubmed:affiliation | Group for Epidemiologic and Clinical Cancer Research (SAKK), Berne, Switzerland. | lld:pubmed |
| pubmed-article:1902076 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1902076 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1902076 | pubmed:publicationType | Comparative Study | lld:pubmed |
